COVID-19 Booster for Children Ages 5-11 in Laredo

Translate to Spanish or other 102 languages!

 The U.S. Food and Drug Administration authorized a single booster of the Pfizer-BioNTech COVID-19 vaccine for individuals 5 through 11 years of age at least five months after completion of their primary series. Image for illustration purposes
The U.S. Food and Drug Administration authorized a single booster of the Pfizer-BioNTech COVID-19 vaccine for individuals 5 through 11 years of age at least five months after completion of their primary series. Image for illustration purposes

Mega Doctor News

- Advertisement -

LAREDO, Texas – The U.S. Food and Drug Administration authorized a single booster of the Pfizer-BioNTech COVID-19 vaccine for individuals 5 through 11 years of age at least five months after completion of their primary series. 

Pfizer’s clinical trial showed that a booster dose of the Pfizer-BioNTech COVID-19 Vaccine prompted a robust immune response in this age group, generating neutralizing antibodies against the SARS-CoV-2 virus regardless of prior SARS-CoV-2 infection. The actions taken by the FDA would make all Americans 5 and older eligible for a booster shot.

“FDA/CDC pediatric booster approval ensures a higher level of COVID-19 protection amongst children over the summer and when returning to school in the fall,” says Dr. Richard Chamberlain, Health Director, “We continue to urge our community to get vaccinated; vaccines work, vaccines are safe, and vaccines save lives. Stay up-to-date with your vaccines”.

- Advertisement -

The City of Laredo Health Department will provide COVID-19 boosters shots to children 5-11 years of age starting Friday, May 20, 2022. Vaccines will be available at the City of Laredo Health Department Clinic located at 2600 Cedar Ave. or across the city of Laredo via our Mobile Health Clinic

For more information or updates, please follow our social media channels at @LaredoHealth or call (956) 236-8311.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

STHS to Host Annual Think Pink Parade to Drive Breast Cancer Awareness, Oct. 3rd

Breast cancer remains one of the most commonly diagnosed cancers among women in the United States and is a leading cause of cancer-related deaths.

DHR Health Enhances Ear, Nose, and Throat Care with Addition of Dr. Tess Hill

As part of its ongoing commitment to expanding access to outstanding healthcare throughout the Rio Grande Valley, DHR Health is pleased to welcome Dr. Tess Hill to its growing team of physicians. Dr. Hill joins DHR Health as an otolaryngologist (ear, nose and throat physician) and looks forward to providing compassionate, patient-centered care.

Accelerator Program Relaunches Oct. 15 with Expanded Focus on AI and Healthcare

AltaCair Foundation, in partnership with Genentech as the 2026 co-host, will host its fourth annual Accelerator summit on Thursday, October 15, 2026, from 8:00 a.m. to 12:00 p.m. at the Harlingen Convention Center.

Lung Cancer Advances Drive Down Overall Mortality Rates

Cancer death rates fell for both men and women from 2019 to 2023, continuing a downward trend that has lasted more than 20 years, according to the 2026 Annual Report to the Nation on the Status of Cancer, published in the journal Cancer. The continued decline in cancer deaths is driven largely by accelerated progress against lung cancer.
- Advertisement -